Here's a breakdown of what the five Twitter IPO underwriters think about TWTR stock right now. Spoiler alert: Some of it sure isn't pretty. More
5 Stocks With Crummy Sales Growth — NAVB CTEL HKTV CUR IMMU
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader. More
5 Stocks With Awful Operating Margin Growth — SYUT CTEL HKTV NYNY IMMU
This week, these five stocks have the worst ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader. More
5 Stocks With Great Sales Growth — INSY IDCC AGM HGSH ESGR
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader. More
5 Stocks With Strong Operating Margin Growth — ATTU IDT MX CALL AHS
This week, these five stocks have the best ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader. More
Don’t Buy Orexigen on Diet Pill Hopes
Orexigen Therapeutics joins VIVUS and Arena Pharmaceuticals in an industry that's brought nothing but disappointment to investors: weight-loss drugs. More
5 Diversified Utilities Stocks to Buy Now
This week, five diversified utilities stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
